Title : Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.

Pub. Date : 2008 Feb 26

PMID : 18231104






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In patients given first-line cisplatin-based regimens (combined with S-1 or irinotecan) (43 patients), low ERCC1 correlated with a higher response rate (low: 55.6% vs high: 18.8%; P=0.008). Irinotecan ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens